Tag: OSA

Benefits of PAP therapy on mortality in 176,014 OSA patients: A French Nationwide Database Analysis

Patients who continued PAP therapy throughout the 1st year increased their survival chances by 39%. Data analysis also revealed that the risk of developing heart failure and hypertension was reduced. ...
Read More

Impact of PAP therapy adherence on outcomes in patients with OSA & COPD

Retrospective database analysis (N=6810) shows PAP usage by patients with OSA and COPD was associated with reduced all-cause hospitalisations, emergency room visits, severe acute exacerbations and hea...
Read More

CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis

A unique analysis of almost half-a-million PAP patients over their first three years of treatment has revealed the importance of considering patient phenotyping and personalised care when developing i...
Read More

Apnea-Hypopnea Index in COPD Exacerbation Requiring NIV with AVAPS

Single-centre prospective study (N=30) finds AHI >5 (vs <5) associated with longer hospital stay, mechanical ventilation & higher percentage of intubation in patients with acute hypercapnic respirator...
Read More

A review of therapies for the overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease

New review discusses obstructive sleep apnoea & other sleep-disordered breathing in patients with COPD. Timely diagnosis and management is key: OSA+COPD increases risk of pulmonary hypertension, cardi...
Read More

NICE GUIDELINE: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s

Diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndr...
Read More